Abbott has a new Vascular division CMO

New Abbott Vascular Chief Medical Officer Dr. Ethan Korngold. [Image from Ethan Korngold on LinkedIn]Abbott (NYSE: ABT) + has appointed Dr. Ethan Korngold as its new divisional VP of medical affairs and chief medical officer for its Vascular business.

Korngold succeeds Dr. Nick West, who spent four years as CMO and divisional VP of global medical affairs at Abbott Vascular. West departed in September to become associate chief medical officer at Shockwave Medical, which Johnson & Johnson is now acquiring.

The new CMO joins Abbott with more than 20 years of medical practice. He most recently served as medical director of interventional cardiology and structural heart at the Providence Heart and Vascular Institute. According to LinkedIn, he spent eight years at Harvard Medical School and Massachusetts General Hospital.

Julie Tyler, Abbott SVP and president of the Vascular unit, welcomed Korngold in a LinkedIn post…

Read more
  • 0

LivaNova names former J&J MedTech exec as chief innovation officer

 

LivaNova (Nasdaq: LIVN) + today announced it appointed Ahmet Tezel as chief innovation officer, effective May 13, 2024.

Ahmet Tezel, LivaNova chief innovation officer [Image courtesy of LinkedIn]Tezel will take on the newly created chief innovation officer position to establish an integrated innovation function at the company and accelerate the development of new technologies.

“I am very pleased to welcome Ahmet to the LivaNova team. At LivaNova, our commitment to pioneering innovation remains unwavering, and Ahmet’s arrival marks a significant step in advancing this vision. With a remarkable track record, Ahmet has led teams that have developed market-leading technologies across diverse medical domains, from bariatric surgery to surgical ophthalmology. As Chief Innovation Officer, Ahmet will advance LivaNova’s ability to create novel solutions and elevate the quality of care in neurological and cardiac…

Read more
  • 0

Former ZimVie exec Rebecca Whitney named CEO of Highridge Medical

Highridge Medical this week announced it appointed Rebecca Whitney as CEO, effective immediately.

Whitney will join the company’s board of directors as part of the appointment. Former CEO Glen Kashuba will transition to CEO of EBI.

Highridge Medical and EBI are portfolio companies of HIG Capital, which earlier this month acquired ZimVie’s spine and EBI Bone Healing businesses. Upon completing the acquisition, former ZimVie Global Spine President Whitney was slated to continue as president of the spine business at Highridge Medical.

“I am excited that Rebecca will now take the helm as CEO of Highridge. Her proven leadership, vision, and unwavering commitment to excellence are the driving forces that will propel Highridge into a promising future,” Highridge Executive Chair Eric Major said in a LinkedIn post. “I am confident that Rebecca will champion innovation and growth.”

Highridge Medical designs and commercial…

Read more
  • 0

Conmed appoints new chief operating officer

Conmed (NYSE: CNMD) + announced that it promoted Patrick Beyer to the newly created role of COO.

Beyer previously served as president of international and global orthopedics at the Largo, Florida-based company. In his new role, his responsibilities include leading commercial businesses, plus operations, distribution, regulatory/quality and customer excellence.

“Pat has been invaluable in driving Conmed’s above-market growth and expanding our presence in key markets,” said Curt R. Hartman, Conmed chair, president, and CEO. “He is an experienced leader with a proven track record of commercial and operational excellence and delivering results, and I look forward to Pat’s continued impact on the organization.”

Beyer joined Conmed in 2014 as president of international. In October 2020, he received a promotion to the role of president of international and global orthopedics. He served in that post for nearly fou…

Read more
  • 0

Medtronic names new chief regulatory officer

Medtronic Chief Regulatory Officer Yarmela Pavlovic [Photo courtesy of Medtronic]Medtronic (NYSE: MDT) + officials today shared that the medtech giant named Yarmela Pavlovic as its new chief regulatory officer.

Pavlovic posted the news on LinkedIn: “I’m excited to share that I’ve recently been named chief regulatory officer for Medtronic. Medtronic products touch the lives of 74 million patients per year, and I’m honored to continue to support our global mission.”

According to her LinkedIn profile, Pavlovic joined Medtronic as VP of regulatory strategy in July 2021. She held that role until April 2023, when she became VP of global regulatory affairs, strategy and policy. Pavlovic was a partner at law firms Manatt, Phelps & Phillips and Hogan Lovells after starting her career as an attorney at Pepper Hamilton in 2003.

As Medtronic’s chief regulatory officer, Pavlovic will lead regulatory affair…

Read more
  • 0

Vantage MedTech names Jim Bartel as CEO

Jim Bartel, CEO of Vantage MedTech [Image courtesy of Vantage MedTech]Vantage MedTech today announced it appointed Jim Bartel as CEO.

Bartel has more than 25 years of leadership experience within the medical device and contract manufacturing industries. He has held various roles in leading marketing, business development and sales teams.

Most recently, Bartel was CEO and board member of Waltek, a private equity-owned casting and machining company in the medical industry, and was president of Spectralytics, a medical device contract manufacturing firm. He has also held leadership roles at Precision ADM and Stratasys.

“Vantage has been on an exciting growth journey, and I’m grateful for the opportunity to serve as CEO. We have a talented team of 150+ medical device engineers with decades of industry expertise. Their dedication to partnering with medical device innovators from concept to realization is what makes Vantage stand apart and is key to o…

Read more
  • 0

Neuromod startup IVEAcare raises $27.5M, names CEO

Minneapolis-based neuromodulation technology developer iVEAcare announced today that it raised $27.5 million in a Series A financing round.

iVEAcare spun out from NuXcel, a medical device accelerator. It seeks to develop and commercialize next-generation neuromodulation technologies to treat chronic diseases.

The company also named Todd Kerkow as its new president and CEO. A medical device industry veteran, Kerkow spent nearly three decades in the industry. His experience spans companies including Guidant, Cameron Health, Boston Scientific and Cardionomic.

Vensana Capital led the financing round, while Treo Ventures, Hatteras Venture Partners and an undisclosed strategic partner participated.

“We are very fortunate to have such an experienced medical device investor group supporting iVEAcare, and I look forward to partnering with them to develop this novel neuromodulation technology,” Kerkow said in a news release. “This Series A…

Read more
  • 0

Bio-Rad names Roop Lakkaraju as CFO

Roop K. Lakkaraju, EVP and CFO of Bio-Rad [Image from LinkedIn]Bio-Rad today announced it appointed Roop K. Lakkaraju as EVP and chief financial officer, effective April 15.

Lakkaraju joins the clinical diagnostics and imaging systems company from Benchmark Electronics where he served as EVP and chief financial officer and was responsible for all finance-related functions since 2018.

“We are pleased to welcome Roop Lakkaraju as our new chief financial officer,” CEO and President Norman Schwartz said in a news release. “Roop’s extensive experience and track record in financial management, operations, mergers and acquisitions, and capital markets transactions will be instrumental in helping us shape and execute our financial strategy.”

Prior to his tenure at Benchmark, Lakkaraju held CFO and senior operational roles at several large, multinational companies, including Support.com and Solectron.

“I am excited to join Bio-Rad as its chief financial offic…

Read more
  • 0

Insulet picks new CFO following McMillan’s move to 3M spinoff

Ana Maria Chadwick [Image courtesy of Insulet]Insulet (Nasdaq: PODD) + announced today that it appointed Ana Maria Chadwick as its new EVP, CFO and treasurer.

Chadwick’s appointment — which goes into effect on April 22, 2024 — follows an extensive search process conducted by Insulet. That search spanned nearly six months after former CFO Wayde McMillan left for 3M’s Solventum healthcare spinoff in October.

Lauren Budden served as interim CFO and treasurer following McMillan’s departure. Insulet plans for her to continue in her role as group VP, chief accounting officer and controller.

Chadwick now joins Acton, Massachusetts-based Insulet, a developer of automated insulin delivery technology, with more than 30 years of experience in propelling growth within organizations.

Get the full story at our sister site, Drug Delivery Business News.

Read more
  • 0

After Intuitive, Shockwave and Avail, Daniel Hawkins is now CEO at AI-powered MRI software startup Vista.ai

Former Avail Medsystems CEO Daniel Hawkins is now president and CEO of Vista.ai. [Photo courtesy of Avail Medsystems]Avail Medsystems founder and former CEO Daniel Hawkins has a new job as president and CEO of MRI software startup Vista.ai.

Palo Alto, California-based Vista.ai (founded and incorporated as HeartVista) makes AI-guided software for automating magnetic resonance imaging (MRI) exams.

Vista.ai was founded by Chief Medical Officer Bob Hu, Chief Architect and Head of Research Juan Santos and Chief Technology Officer William Overall. Its advisory board includes Stanford University doctors and professors and the radiology chair at the University of Wisconsin–Madison.

The company won FDA 510(k) clearances for its HeartVista Workstation with RTHawk application software for the acquisition of real-time and accelerated images from GE Healthcare whole-body MRI systems in 2014, 2017 and 2017. In 2019, the FDA cleared the company’s AI-assisted One Cli…

Read more
  • 0

Medtronic’s Respiratory Interventions unit president is leaving

Outgoing Medtronic Respiratory Interventions President Ariel Mactavish. [Image from Ariel Mactavish on LinkedIn]Ariel Mactavish, president of the Respiratory Interventions unit at Medtronic (NYSE: MDT) + , announced that she is departing her post at the medtech giant.

In a post on LinkedIn, Mactavish explained her decision to depart:

“After 12 rewarding years, I have decided to leave Medtronic and I want to take the opportunity [to] share my deepest gratitude for the amazing work of our team and their unwavering commitment to our patients and customers over the last several years together,” she wrote.

Mactavish’s departure comes shortly after Medtronic announced major changes within her unit. The company said last month that it plans to exit the ventilator market.

That decision came more than a year after Medtronic said it would spin off its Patient Monitoring and Respiratory Interventions b…

Read more
  • 0

BD names new president of BD Surgery

President of BD Surgery Rian Seger [Image courtesy of BD]BD this week announced it appointed Rian Seger as president of BD Surgery, effective April 1.

Seger will be responsible for driving the global strategic, operational and commercial performance of BD Surgery and will report to EVP and President of Interventional Rick Byrd. He replaces Brooke Story who is stepping down to focus on personal matters.

Before becoming president of BD Surgery, Seger was VP and general manager of BD’s Medication Delivery Solutions business unit within the BD Medical segment.

“Rian has more than 20 years of executive experience with proven leadership capabilities that help address unmet needs in health care,” Byrd said in a news release. “Re-joining BD Surgery strongly aligns with Rian’s passion for driving better outcomes for surgeons and patients. With his wealth of experience and a proven track record of delivering results and developing teams, he will be well-suited …

Read more
  • 0